Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Hassfjell, S; Ingebrigtsen, K; Bruland, OS
   Synthesis, purification and biodistribution of (205)-Bi-DOTMP, visualizingbone deposition patterns with autoradiography
   NUCLEAR MEDICINE AND BIOLOGY
   
   S. Hassfjell et al., "Synthesis, purification and biodistribution of (205)-Bi-DOTMP, visualizingbone deposition patterns with autoradiography", NUCL MED BI, 28(4), 2001, pp. 425-433
2. Hassfjell, S
   A Pb-212 generator based on a Th-228 source
   APPLIED RADIATION AND ISOTOPES
   
   S. Hassfjell, "A Pb-212 generator based on a Th-228 source", APPL RAD IS, 55(4), 2001, pp. 433-439
3. Whitlock, JL; Roeske, JC; Dietz, ML; Straus, CM; Hines, JJ; Horwitz, EP; Reba, RC; Rotmensch, J
   Radionuclide therapy for the treatment of microscopic ovarian carcinoma: An overview
   INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH
   
   J.L. Whitlock et al., "Radionuclide therapy for the treatment of microscopic ovarian carcinoma: An overview", IND ENG RES, 39(9), 2000, pp. 3135-3139
4. Nikula, TK; McDevitt, MR; Finn, RD; Wu, CC; Kozak, RW; Garmestani, K; Brechbiel, MW; Curcio, MJ; Pippin, CG; Tiffany-Jones, L; Geerlings, MW; Apostolidis, C; Molinet, R; Geerlings, MW; Gansow, OA; Scheinberg, DA
   Alpha-emitting bismuth cyclohexylbenzyl DTPA constructs of recombinant humanized anti-CD33 antibodies: Pharmacokinetics, bioactivity, toxicity and chemistry
   JOURNAL OF NUCLEAR MEDICINE
   
   T.K. Nikula et al., "Alpha-emitting bismuth cyclohexylbenzyl DTPA constructs of recombinant humanized anti-CD33 antibodies: Pharmacokinetics, bioactivity, toxicity and chemistry", J NUCL MED, 40(1), 1999, pp. 166-176
5. MIRZADEH S
   GENERATOR-PRODUCED ALPHA-EMITTERS
   Applied radiation and isotopes
   
   S. Mirzadeh, "GENERATOR-PRODUCED ALPHA-EMITTERS", Applied radiation and isotopes, 49(4), 1998, pp. 345-349
6. MCDEVITT MR; SGOUROS G; FINN RD; HUMM JL; JURCIC JG; LARSON SM; SCHEINBERG DA
   RADIOIMMUNOTHERAPY WITH ALPHA-EMITTING NUCLIDES
   European journal of nuclear medicine
   
   M.R. Mcdevitt et al., "RADIOIMMUNOTHERAPY WITH ALPHA-EMITTING NUCLIDES", European journal of nuclear medicine, 25(9), 1998, pp. 1341-1351
7. POUPAKI I
   COMPLETE ANALYSIS OF EXPERIMENTAL MULTICOMPARTMENT DECAY CURVES FROM ENVIRONMENTAL-SAMPLES
   Fresenius environmental bulletin
   
   I. Poupaki, "COMPLETE ANALYSIS OF EXPERIMENTAL MULTICOMPARTMENT DECAY CURVES FROM ENVIRONMENTAL-SAMPLES", Fresenius environmental bulletin, 6(5-6), 1997, pp. 349-354
8. HASSFJELL SP; BRULAND OS; HOFF P
   BI-212-DOTMP - AN ALPHA-PARTICLE EMITTING BONE-SEEKING AGENT FOR TARGETED RADIOTHERAPY
   Nuclear medicine and biology
   
   S.P. Hassfjell et al., "BI-212-DOTMP - AN ALPHA-PARTICLE EMITTING BONE-SEEKING AGENT FOR TARGETED RADIOTHERAPY", Nuclear medicine and biology, 24(3), 1997, pp. 231-237
9. ROTMENSCH J; WHITLOCK JL; SCHWARTZ JL; HINES JJ
   IN-VITRO STUDIES USING THE ALPHA-EMITTER BI-212 - DEVELOPMENT OF THERAPY FOR MICROSCOPIC CARCINOMA
   Radiochimica Acta
   
   J. Rotmensch et al., "IN-VITRO STUDIES USING THE ALPHA-EMITTER BI-212 - DEVELOPMENT OF THERAPY FOR MICROSCOPIC CARCINOMA", Radiochimica Acta, 79(2), 1997, pp. 127-130
10. PRESSYANOV DS
    INTEGRATED MEASUREMENTS OF PB-212 AND BI-212 IN THE AIR BY ROTATING FILTERS
    Health physics
    
    D.S. Pressyanov, "INTEGRATED MEASUREMENTS OF PB-212 AND BI-212 IN THE AIR BY ROTATING FILTERS", Health physics, 68(2), 1995, pp. 261-265
11. HASSFJELL SP; HOFF P; BRULAND OS; ALSTAD J
    PB-212 BI-212-EDTMP-SYNTHESIS AND BIODISTRIBUTION OF A NOVEL BONE SEEKING ALPHA-EMITTING RADIOPHARMACEUTICAL/
    Journal of labelled compounds & radiopharmaceuticals
    
    S.P. Hassfjell et al., "PB-212 BI-212-EDTMP-SYNTHESIS AND BIODISTRIBUTION OF A NOVEL BONE SEEKING ALPHA-EMITTING RADIOPHARMACEUTICAL/", Journal of labelled compounds & radiopharmaceuticals, 34(8), 1994, pp. 717-734
12. HARTMANN F; HORAK EM; GARMESTANI K; WU CC; BRECHBIEL MW; KOZAK RW; TSO J; KOSTEINY SA; GANSOW OA; NELSON DL; WALDMANN TA
    RADIOIMMUNOTHERAPY OF NUDE-MICE BEARING A HUMAN INTERLEUKIN-2 RECEPTOR ALPHA-EXPRESSING LYMPHOMA UTILIZING THE ALPHA-EMITTING RADIONUCLIDE-CONJUGATED MONOCLONAL-ANTIBODY BI-212-ANTI-TAC
    Cancer research
    
    F. Hartmann et al., "RADIOIMMUNOTHERAPY OF NUDE-MICE BEARING A HUMAN INTERLEUKIN-2 RECEPTOR ALPHA-EXPRESSING LYMPHOMA UTILIZING THE ALPHA-EMITTING RADIONUCLIDE-CONJUGATED MONOCLONAL-ANTIBODY BI-212-ANTI-TAC", Cancer research, 54(16), 1994, pp. 4362-4370